Profile
| Metric | Value |
|---|---|
| Full Name | Labcorp Holdings Inc. |
| Ticker | NYSE: LH |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | labcorp.com |
| Employees | 70,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $270.87 | |
| Price, 1D Change | +0.74% | |
| Market Cap | $22B | |
| TTM Dividend Yield | 1.06% | |
| PE Ratio | 26.60 | |
| Beta | 0.61 | |
| Revenue | $13B | |
| Revenue, 1Y Change | +6.97% | |
| EPS | $8.84 | |
| EPS, 1Y Change | +85.24% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.72 | |
| Next Ex-Dividend | $0.72 | |
| Last Split | 291:250 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $8.84 | |
| EPS Estimate | $16.33 | |
| EPS Est. Change | +84.73% | |
| Revenue | $13.01B | |
| Revenue Estimate | $13.99B | |
| Revenue Est. Change | +7.57% | |
| Current Price | $270.87 | |
| Price Target | - | $303.00 |
| Price Tgt. Change | - | +11.86% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $13.54 | $4.77 | -64.76% | |
| $14.52 | $8.84 | -39.13% | |
| $16.33 | N/A | +84.73% | |
| $17.52 | N/A | +98.20% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.15B | $12.16B | +0.13% | |
| $12.98B | $13.01B | +0.24% | |
| $13.99B | N/A | +7.57% | |
| $14.62B | N/A | +12.41% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +13.44% | |
| Price, 3Y | +25.26% | |
| Market Cap, 1Y | +12.76% | |
| Market Cap, 3Y | +17.73% | |
| Revenue, 1Y | +6.97% | |
| Revenue, 3Y | -19.30% | |
| EPS, 1Y | +85.24% | |
| EPS, 3Y | -63.75% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $270.87 | |
| SMA 200 | $259.20 | |
| SMA 200 vs Price | -4.31% | |
| SMA 50 | $259.51 | |
| SMA 50 vs Price | -4.19% | |
| Beta | 0.61 | |
| ATR | $5.63 | |
| 14-Day RSI | 65.37 | |
| 10-Day Volatility | 29.25% | |
| 1-Year Volatility | 24.64% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.72 | |
| Upcoming | $0.72 | |
| Dividend Yield | 1.06% | |
| Total Dividend | $2.88 | |
| Dividends Paid | $243.10M | |
| Payout Ratio | 32.54% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $13.01B | |
| EPS | $8.84 | |
| Gross Profit | $3.37B | |
| Gross Margin | 25.89% | |
| Operating Profit | $1.14B | |
| Operating Margin | 8.75% | |
| Net Income | $747.10M | |
| Net Margin | 5.73% | |
| EBITDA | $1.81B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.90 | |
| Current Ratio | 1.44 | |
| Quick Ratio | 1.30 | |
| - | ||
| F-Score | 9 | |
| Altman Z-Score | 2.95 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 26.60 | |
| PS Ratio | 1.63 | |
| PB Ratio | 2.58 | |
| EV/EBITDA | 13.89 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $8.05B | |
| Cash & Equivalents | $1.52B | |
| Total Assets | $18.38B | |
| Current Assets | $4.81B | |
| Total Liabilities | $10.31B | |
| Current Liabilities | $3.33B | |
| Total Debt | $7.27B | |
| Short Term Debt | $1.19B | |
| Accounts Payable | $875.80M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $12.26B | |
| Operating Expenses | $2.23B | |
| Cost Of Goods Sold | $9.64B | |
| SG&A | $0.00 | |
| D&A | $643.50M | |
| Interest Expense | $0.00 | |
| Income Tax | $212.40M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $1.59B | |
| CFI | -$1.37B | |
| CFF | $779.90M | |
| Capex | $489.90M | |
| Free Cash Flow | $1.10B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| UBS | → | |
| UBS | → | |
| Mizuho | → | |
| Evercore ISI Group | → | |
| Barclays | → | |
| UBS | → | |
| Truist Securities | → | |
| Morgan Stanley | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
Screeners with LH
FAQ
What is the ticker symbol for Labcorp Holdings Inc.?
The ticker symbol for Labcorp Holdings Inc. is NYSE:LH
Does Labcorp Holdings Inc. pay dividends?
Yes, Labcorp Holdings Inc. pays dividends. The last payment was $0.72, with an ex-dividend date on November 26, 2025
What sector is Labcorp Holdings Inc. in?
Labcorp Holdings Inc. is in the Healthcare sector
What industry is Labcorp Holdings Inc. in?
Labcorp Holdings Inc. is in the Diagnostics & Research industry
What country is Labcorp Holdings Inc. based in?
Labcorp Holdings Inc. is headquartered in United States
When did Labcorp Holdings Inc. go public?
Labcorp Holdings Inc. initial public offering (IPO) was on March 29, 1990
Is Labcorp Holdings Inc. in the S&P 500?
Yes, Labcorp Holdings Inc. is included in the S&P 500 index
Is Labcorp Holdings Inc. in the NASDAQ 100?
No, Labcorp Holdings Inc. is not included in the NASDAQ 100 index
Is Labcorp Holdings Inc. in the Dow Jones?
No, Labcorp Holdings Inc. is not included in the Dow Jones index
When was Labcorp Holdings Inc. last earnings report?
Labcorp Holdings Inc.'s most recent earnings report was on October 28, 2025
When does Labcorp Holdings Inc. report earnings?
The next expected earnings date for Labcorp Holdings Inc. is February 17, 2026
Data Sources & References
- LH Official Website www.labcorp.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/920148/000092014825000093/0000920148-25-000093-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/920148/000092014825000032/0000920148-25-000032-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- LH Profile on Yahoo Finance finance.yahoo.com/quote/LH
- LH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lh
